AzTrials
AzTrials

DyspneaNCT05742113

Emergency Classification According to Fingertip Circulation

A study testing Masimo Radical-7 in people with Dyspnea, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dyspnea is one of the most common reasons for admission to the emergency department[1]. Oxygen saturation has great importance in determining the triage status of patients admitted to the hospital with dyspnea and planning the emergency treatment [2]. Read more about this study

Who is it for?
Ages 18 to 96 years
Conditions the study is for
Dyspnea
What is being tested?
Masimo Radical-7
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,490 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2019to 1 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 96 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients over the age of 18 who presented with dyspnea
  • whose perfusion index values were measured at the time of first admission (arrival time), at the first hour and the second hour of admission were included in the study

Who cannot join

  • Patients who applied due to the mechanism of trauma,
  • patients with known vascular disease (Buerger's disease, peripheral artery disease, etc.), -patients with COVID-19 PCR positivity
  • whose perfusion index measurement could not be completed due to hospitalization or discharge were excluded from the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Manisa Celal Bayar University

    Manisa, 45030

Other trials in Turkey (Türkiye)

About this study

Official title: DYSPNEA: PERFUSION INDEX and TRIAGE STATUS (the Name of the Project)

Dyspnea is one of the most common reasons for admission to the emergency department[1]. Oxygen saturation has great importance in determining the triage status of patients admitted to the hospital with dyspnea and planning the emergency treatment [2].

Peripheral perfusion index (PI), which shows tissue oxygenation is a noninvasive way of demonstrating tissue perfusion in critically ill patients. Studies have shown that PI is an accurate, fast and reliable pulse oximetry-based indicator of tissue perfusion [3-5]. PI shows the perfusion status of the tissue in the applied area for an instant and a certain time interval. The PI value ranges from 0.02% (very weak) to 20% (strong) [6].

Read more

Triage scales are used to distinguish emergency and non-emergency patients. The emergency triage system is used to quickly determine the care priorities of patients during admission to the emergency department[7,8].

It is important to make the triage classification for dyspnea in emergency services quickly and accurately to start the treatment protocols as early as. In this study, the investigators aimed to determine the relationship between perfusion index and the emergency triage classification in patients admitted to the emergency department with dyspnea.

Read the detailed description

Purpose: To determine the effect of PI measurement on the emergency triage classification in patients with dyspnea.

Methods: Adult patients who presented with dyspnea and whose perfusion index values were measured with Masimo Radical-7 device at the time of admission, at the first hour and the second hour of admission were included in the study. The PI and oxygen saturation measured by finger probes were compared and the superiority of their effects on the emergency triage classification was compared.

Conditions
Dyspnea
Being tested
Masimo Radical-7
Keywords
Dyspnea, Emergency, Perfusion index, Triage
Medical subject headings
Dyspnea, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Masimo Radical-7Device

    perfusion index measuring device

Study groups in NCT05742113
Study groupRoleWhat they receive
Triage status redExperimentalthe relationship between the perfusion index and the emergency triage classification in patients admitted to the emergency department with dyspnea.
Receives: Device: Masimo Radical-7

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perfusion index use for triage status

    for determination of triage status of patients with dyspnea with using perfusion index

    Measured: perfusion index measurement at the time of first admission to hospital

  2. Perfusion index use for triage status

    for determination of triage status of patients with dyspnea with using perfusion index

    Measured: perfusion index measurement at the time of the first hour after admission to hospital

  3. Perfusion index use for triage status

    for determination of triage status of patients with dyspnea with using perfusion index

    Measured: perfusion index measurement at the time of the second hour after admission to hospital

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2023
  2. Study start1 Jan 2019
  3. Primary completion1 Jan 2021
  4. Study completion1 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,490 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05742113
Sponsor's protocol ID
10.10.2018 and 20.478.486
Other IDs
Manisa Celal Bayar University
Status last verified
Mar 2024
First submitted
31 Jan 2023
Last updated
15 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The result will be explained in the manuscript when published.

Questions about this trial

What is this clinical trial studying?

A study testing Masimo Radical-7 in people with Dyspnea, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perfusion index use for triage status (time frame: perfusion index measurement at the time of first admission to hospital). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in